Oak Thistle LLC Makes New Investment in Cigna Group $CI

Oak Thistle LLC acquired a new stake in Cigna Group (NYSE:CI) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 17,201 shares of the health services provider’s stock, valued at approximately $4,958,000. Cigna Group accounts for about 0.8% of Oak Thistle LLC’s investment portfolio, making the stock its 7th largest holding.

Other hedge funds also recently made changes to their positions in the company. Pathway Financial Advisers LLC grew its position in Cigna Group by 2.3% during the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in Cigna Group by 1.0% in the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after acquiring an additional 35 shares in the last quarter. NDVR Inc. lifted its position in shares of Cigna Group by 5.0% during the 2nd quarter. NDVR Inc. now owns 779 shares of the health services provider’s stock valued at $258,000 after acquiring an additional 37 shares during the period. HBK Sorce Advisory LLC grew its holdings in shares of Cigna Group by 3.1% during the 2nd quarter. HBK Sorce Advisory LLC now owns 1,263 shares of the health services provider’s stock worth $418,000 after purchasing an additional 38 shares in the last quarter. Finally, Legacy Financial Advisors Inc. grew its holdings in shares of Cigna Group by 2.9% during the 1st quarter. Legacy Financial Advisors Inc. now owns 1,400 shares of the health services provider’s stock worth $461,000 after purchasing an additional 39 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on CI. UBS Group set a $294.00 price target on Cigna Group in a research note on Wednesday, November 12th. Barclays dropped their target price on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research report on Friday, October 31st. The Goldman Sachs Group reduced their price target on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Cowen set a $333.00 price objective on shares of Cigna Group in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $331.83.

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani bought 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE:CI opened at $276.12 on Wednesday. The firm has a 50 day simple moving average of $279.29 and a 200 day simple moving average of $293.37. The company has a market cap of $73.76 billion, a price-to-earnings ratio of 12.18, a PEG ratio of 1.01 and a beta of 0.26. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the prior year, the business earned $7.51 earnings per share. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.